Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$34.32 - $57.55 $123,346 - $206,834
3,594 New
3,594 $201,000
Q3 2022

Nov 14, 2022

BUY
$28.48 - $52.59 $283,319 - $523,165
9,948 New
9,948 $283,000
Q4 2021

Feb 14, 2022

BUY
$135.05 - $182.59 $427,028 - $577,349
3,162 New
3,162 $471,000
Q3 2021

Nov 15, 2021

SELL
$145.58 - $192.14 $194,640 - $256,891
-1,337 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$134.22 - $202.37 $357,427 - $538,911
-2,663 Reduced 66.57%
1,337 $262,000
Q2 2020

Aug 14, 2020

BUY
$58.39 - $89.31 $233,560 - $357,240
4,000 New
4,000 $357,000
Q1 2020

May 15, 2020

SELL
$51.57 - $106.62 $200,865 - $415,284
-3,895 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$46.07 - $79.54 $179,442 - $309,808
3,895 New
3,895 $297,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.